FDA NDC Directory · JSON-LD · Markdown

Liothyronine sodium

NDC 70377-116 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerBiocon Pharma Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA218070
Dosage form / routeTABLET · ORAL
Active ingredientsLIOTHYRONINE SODIUM (50 ug/1)
Marketing started20240212
Package count3

External sources

Source: openFDA. Public-domain (CC0).